AAFP CEO Shawn Martin plans to push Congress to codify ACIP’s funding and structure, limiting HHS power after RFK Jr.’s ...
RevMed's Rasonque nets $198M; Madrigal sued over Rezdiffra data; Rezera eyes $181M IPO; ANI bids $560M for Egetis; Cloudbreak ...
Caldera Therapeutics is going back to its existing partner Qyuns Therapeutics for a IL-17xTL1A bispecific antibody, while ...
Ellipsis, which uses voice AI to screen and chat with patients, bought Kouper Health, which carries out ...
Oxford spinout Alethio raises $90M Series A co-led by Sofinnova and RA Capital to take ET antibody ATX-011 into the clinic.
Kamau Therapeutics shares early data on nula-cel 2.0 for sickle cell disease; 3 patients show no pain crises or transfusion ...
Sanofi drops SAR448272, a STAT6 degrader developed with Nurix Therapeutics, after Phase 1 discontinuation. Nurix shares fell ...
CVS Health (Aetna, Caremark, Oak Street) and CVS Pharmacy. CEO David Joyner leads health unit; Prem Shah leads pharmacy.
Biotech pessimism about China more than doubles in Q3 BPSI, making it biopharma’s No. 2 worry, while Big Pharma stays net ...
J&J’s trispecific ramantamig shows 100% ORR in newly diagnosed myeloma, Tibsovo hits EFS in frontline AML, Calquence combo ...
Spyre drops SPY072 for rheumatic diseases after SKYWAY trial failures; Ideaya halts darovasertib UM trial; United ...
Novo raises 2026 outlook to flat sales as the Wegovy pill outsells Lilly’s Foundayo; CFO Knudsen hands over to Galderma’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results